Eli Lilly | 売上原価



Cost Of Sales 変化する 日付
AbbVie USD 4B 394M 2025-03
Abbott USD 4.44B 502M 2025-03
ALKERMES USD 62.12M 984K 2024-12
Amgen USD 3.11B 198M 2024-12
AstraZeneca USD 2.24B 484M 2025-03
Baxter International USD 1.74B 73M 2024-12
Biogen USD 583.5M 55.2M 2024-12
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Drreddys Laboratories INR 34.53B 2.14B 2024-12
Eli Lilly USD 2.4B 233M 2024-12
Gilead Sciences USD 1.54B 41M 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
Glaxosmithkline GBP 2.52B 199M 2024-12
Indivior 44M 21M 2025-03
J&J USD 7.3B 189M 2025-03
Medtronic USD 2.78B 160M 2025-01
Merck USD 2.76B 944M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.32B 90M 2024-12
Novartis USD 3.31B 73M 2024-12
Novo Nordisk 11.31B 1.03B 2024-09
Perrigo USD 752.4M 69.3M 2024-12
Pfizer USD 2.59B 3.06B 2025-03
Prestige Brands USD 129.27M 2.86M 2024-12
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.89B 618M 2025-03
Sanofi EUR 2.27B 1.81B 2024-12
United Therapeutics USD 277.5M 201.6M 2025-03
Zoetis USD 707M 8M 2024-12



Eli Lilly 売上原価 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - May 2025.